Digestive Cancers Europe
Digestive Cancers Europe (DiCE) is a Brussels-based non-profit umbrella organization uniting national patient organizations across Europe to advocate for patients with colorectal, gastric, oesophageal, liver, pancreatic, and rare digestive cancers through awareness campaigns, multilingual educational resources, clinical trial databases, and EU-level policy engagement.
- Company typePrivate
- Founded2018
- HeadquartersBrussels, Belgium
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Digestive Cancers Europe does
Digestive Cancers Europe (DiCE) is a Brussels-headquartered non-profit umbrella organization (asbl/vzw under Belgian law) that unites national patient organizations dedicated to digestive cancers across Europe. Its primary users are patients with colorectal, gastric, oesophageal, liver, pancreatic, rare, and hereditary digestive cancers, their carers, member patient organizations, healthcare professionals, and EU/national policymakers. DiCE operates community-led go-to-market: it mobilizes members through awareness campaigns (ECCAM, Oesophageal/Gastric/Pancreatic/Liver Cancer Awareness Months, Fun Run), educational publications available in multiple European languages, a multilingual website, the My DiCE Companion and StepApp mobile applications, and the Colorectal Cancer Navigator — alongside databases for clinical trials and pharmaceutical treatments.
Its underlying technology stack consists of a WordPress-based website (digestivecancers.eu), a clinical trials and drug information database, two mobile applications (My DiCE Companion, StepApp), an event platform for the Fun Run including a poster-creation tool, an EU Health Policy Platform hosted Stakeholder Network on CRC Screening, and a publications library. DiCE does not develop proprietary AI/ML, APIs, or custom enterprise software; its "platform" is fundamentally organizational rather than technical.
DiCE generates revenue through individual donations (preset tiers of €25/€50/€100/€250 plus bank transfers), corporate sponsorships (Fun Run tiers: Platinum BeOne; Gold Daiichi-Sankyo, Bayer, Servier; Silver Astellas), EU-funded projects, and grants. It does not charge patients for services. It disburses €5,000 annually via the Wolfram Nolte Memorial Award to member organizations and supports EUPATI Patient Expert Training grants, positioning itself as a net funder to the network. Governance is provided by a Board chaired by Dora Constantinides, with Stefan Gijssels as CEO, Prof. Dr. Eric Van Cutsem as Medical Director and co-founder, and Ruel Jacob as Communications Manager.
Digestive Cancers Europe firmographics
Firmographics- Name
- Digestive Cancers Europe
- Legal name
- Digestive Cancers Europe vzw/asbl
- Website
- https://digestivecancers.eu
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Digestive Cancers Europe (DiCE) is a Brussels-based non-profit umbrella organization uniting national patient organizations across Europe to advocate for patients with colorectal, gastric, oesophageal, liver, pancreatic, and rare digestive cancers through awareness campaigns, multilingual educational resources, clinical trial databases, and EU-level policy engagement.
- Ownership category
- akta.pro rank
Digestive Cancers Europe industry classification
Industry- Product category
- Patient Advocacy and Nonprofit Healthcare Services
- NAICS
- Individual and Family Services (6241)
- SIC
- Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Digestive Oncology (GI Cancer Care) (HLAKAEAF)
- akta.pro secondary industries
- Monitoring, Evaluation, Research & Learning (MERL) for Global Health (BPADAIAO), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Digestive Cancers Europe is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Digestive Cancers Europe business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others, Technology or R&D
Revenue model
- Donations and Fundraising: DiCE generates revenue through individual and organizational donations. They accept donations via their website with preset amounts (€25, €50, €100, €250) and bank transfers.
- Grants and Awards: DiCE provides grants to member organizations including the €5,000 Wolfram Nolte Memorial Award for colorectal cancer projects. Funding is also received from EU-funded projects and partnerships.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Digestive Cancers Europe product offering
Product offeringCore offering
Digestive Cancers Europe is a non-profit umbrella organisation that delivers patient advocacy, educational resources, and awareness campaigns for people affected by digestive cancers across Europe. It provides free digital tools (My DiCE Companion app, Clinical Trials Database, Drug Database, Colorectal Cancer Navigator), multilingual publications, and grant/training programs (e.g., Wolfram Nolte Memorial Award, EUPATI training) to member patient organisations. Its core activities also include EU-level policy advocacy and stakeholder mobilisation.
Product overview
Digestive Cancers Europe (DiCE) operates as a European non-profit umbrella organization offering a portfolio of patient-focused digital resources, information tools, and educational programs. The core offerings include patient companion apps (My DiCE Companion, StepApp), clinical and drug information databases, patient navigation tools, awareness campaign platforms (Fun Run 2026 with poster creation tool), a publications library, and grant/training programs for member organizations. These products serve patients, carers, and patient organizations across Europe to improve outcomes in digestive cancers.
Differentiator
Problem solved
Functional benefit
Products and services
- My DiCE Companion A companion mobile app providing resources and support for digestive cancer patients.
- StepApp A mobile application supporting awareness campaigns and tracking physical activity for digestive cancer awareness.
- Clinical Trials Database A searchable database of recruiting and ongoing clinical trials for digestive cancers, allowing patients to find and participate in research.
- Drug Database A pharmaceutical treatments database for digestive cancers providing information on available medications.
- Colorectal Cancer Navigator A guided resource helping colorectal cancer patients navigate their care journey.
- Fun Run 2026 Event Platform An event platform with registration, training plans, and poster creation tool for the Fun Run awareness campaign in Munich.
- Poster Tool An online tool allowing participants to create personalized posters for the Fun Run awareness campaign.
- Publications Library A library of publications including reports, guides, factsheets, and educational materials on digestive cancers.
- Wolfram Nolte Memorial Award An annual award of €5,000 granted to member organizations for innovative colorectal cancer patient/carer projects.
- EUPATI Patient Expert Training Grant A grant program supporting DiCE members to attend the EUPATI Patient Expert Training Programme covering medicines R&D processes.
Quantifiable outcome
- 85+ network members in Thematic Network on CRC Screening
- +2 more outcomes
Companies that use Digestive Cancers Europe
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Digestive Cancers Europe technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Digestive Cancers Europe partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, major and minor.
- European Liver Patients' Association (ELPA)coreJoint hosting of European policy event 'Liver Cancer: No Patient Left Behind, Optimising the European Response' at the European Parliament on October 12, 2022. Brings together experts, policymakers, patients, and stakeholders in liver cancer.
- Outdoor Against Cancer (OAC)coreJoint partnership for the annual Fun Run event. OAC and DiCE co-host the Fun Run & Walk in Munich to raise awareness of digestive cancers and promote outdoor activity and healthy lifestyles. The 2026 event is scheduled for July 3 at Riemer Park, Munich.
- BeOnecorePlatinum Partner for the Fun Run 2026 event. Supports the joint awareness and fundraising initiative between DiCE and Outdoor Against Cancer.
- Daiichi-SankyomajorGold Partner for the Fun Run 2026 event. Supports awareness and fundraising activities for digestive cancers.
- BayermajorGold Partner for the Fun Run 2026 event. Supports awareness and fundraising activities for digestive cancers.
- ServiermajorGold Partner for the Fun Run 2026 event. Supports awareness and fundraising activities for digestive cancers.
- AstellasminorSilver Partner for the Fun Run 2026 event.
- NovartisminorCorporate sponsor supporting EuropaColon Portugal's palliative care project (Wolfram Nolte Memorial Award funded project).
- Pierre FabreminorCorporate sponsor supporting EuropaColon Portugal's palliative care project (Wolfram Nolte Memorial Award funded project).
- RocheminorCorporate sponsor supporting EuropaColon Portugal's palliative care project (Wolfram Nolte Memorial Award funded project).
- European Commission (EU Health Policy Platform)coreDiCE leads the Thematic Network on CRC Screening on the EU Health Policy Platform, officially presenting conclusions to the European Commission. The Network includes 85 members and has transformed into a permanent Stakeholder Network.
- YouTumor.orgminorDiCE shares information about the YouTumor.org resource, an Italian oncologist-led initiative providing cancer information in simple terms in multiple languages.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Digestive Cancers Europe competitors and assessment
Company assessmentBroad incumbents
- Cancer Research UK: Cancer Research UK is one of the world's largest cancer research and awareness charities, with a digestive cancer research portfolio — broadly comparable as a major cancer non-profit but UK-focused and far larger than DiCE in scale and budget.
- American Cancer Society: American Cancer Society is the largest US cancer non-profit, addressing digestive cancers as part of a broad portfolio — broadly comparable as a major cancer advocacy organization, though US-focused rather than pan-European.
- European Society for Medical Oncology (ESMO): ESMO is the leading European professional society for medical oncology, including digestive cancer tracks — broadly comparable as a European oncology stakeholder engaging in policy and education, but representing clinicians rather than patients.
Direct peers
- European Liver Patients' Association (ELPA): ELPA is the European umbrella for liver disease patient organizations and an active strategic partner of DiCE — directly comparable as a single-organ-disease European patient umbrella that co-hosts EU Parliament events and advocates on liver cancer policy.
- Pancreatic Cancer Europe: Pancreatic Cancer Europe is a multi-stakeholder platform specifically focused on pancreatic cancer across Europe — a directly comparable disease-specific European advocacy platform that competes for member attention and pharma funding within DiCE's portfolio.
- EuropaColon: EuropaColon is a European colorectal cancer patient advocacy organization that historically founded DiCE and continues to operate alongside it — a directly comparable disease-specific patient umbrella addressing the largest single cancer within DiCE's scope.
- European Cancer Patient Coalition (ECPC): ECPC is the largest European umbrella cancer patient organization, working across all cancer types in Brussels — directly comparable to DiCE as a pan-European patient advocacy umbrella operating from Brussels with EU policy engagement, though broader in disease scope.
Emerging players
- Lynch Syndrome International: Lynch Syndrome International is a niche hereditary cancer patient organization — comparable as an emerging disease-specific player within DiCE's hereditary/rare digestive cancer portfolio, competing for patient awareness and funding in a specific subtype.
- World Cancer Research Fund International: WCRF International is a cancer prevention-focused charity addressing diet and lifestyle links to cancers including digestive — comparable as an emerging player with adjacent (prevention-focused) activities that intersect DiCE's awareness mission.
Others
- EURORDIS - Rare Diseases Europe: EURORDIS is the European umbrella for rare disease patient organizations — adjacent comparable as a European-level patient umbrella operating in Brussels with EU policy focus, with overlap in DiCE's rare digestive cancers portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Digestive Cancers Europe social profiles
Digital presenceDigestive Cancers Europe financial estimates
Financial estimateRevenue estimate
Valuation estimate
Digestive Cancers Europe leadership team
Management profileNumber of profiles
Profiles4 records
Digestive Cancers Europe funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Digestive Cancers Europe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Digestive Cancers Europe
What does Digestive Cancers Europe do?
Digestive Cancers Europe is a non-profit umbrella organisation that delivers patient advocacy, educational resources, and awareness campaigns for people affected by digestive cancers across Europe. It provides free digital tools (My DiCE Companion app, Clinical Trials Database, Drug Database, Colorectal Cancer Navigator), multilingual publications, and grant/training programs (e.g., Wolfram Nolte Memorial Award, EUPATI training) to member patient organisations. Its core activities also include EU-level policy advocacy and stakeholder mobilisation.
Is Digestive Cancers Europe a public or private company?
Digestive Cancers Europe is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Digestive Cancers Europe founded?
Digestive Cancers Europe was founded in 2018. It employs 11 to 50 people.
Where is Digestive Cancers Europe based?
Digestive Cancers Europe is headquartered in Brussels, Belgium, in the Europe region.
How does Digestive Cancers Europe make money?
Two revenue lines are on record. Donations and Fundraising is the primary driver. The others are grants and Awards.
Who are Digestive Cancers Europe's main competitors?
Broad incumbents on record are Cancer Research UK, American Cancer Society and European Society for Medical Oncology (ESMO). Direct peers are European Liver Patients' Association (ELPA), Pancreatic Cancer Europe, EuropaColon and European Cancer Patient Coalition (ECPC). Emerging players are Lynch Syndrome International and World Cancer Research Fund International. EURORDIS - Rare Diseases Europe is listed as an others.
Does Digestive Cancers Europe have an API?
No public API is recorded for Digestive Cancers Europe.
What industry is Digestive Cancers Europe in?
Digestive Cancers Europe's product category is Patient Advocacy and Nonprofit Healthcare Services. Its primary akta.pro industry code is HLAKAEAF, Digestive Oncology (GI Cancer Care), with a secondary code of BPADAIAO, Monitoring, Evaluation, Research & Learning (MERL) for Global Health. Its NAICS code is 6241 and its SIC code is 8000.